The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Redefining What Mental Health Facilities Look Like
Managing High-Volume Laundry Operations 
University of Pittsburgh Medical Center Falls Victim to Vendor Data Breach
Optimizing the Engineering Design of Ambulatory Care Facilities
Construction Completed on Washington Health Urgent Care Facility in California